ZK INTERNATIONAL GROUP CO LT (ZKIN) Fundamental Analysis & Valuation

NASDAQ:ZKIN • VGG9892K2092

Current stock price

1.61 USD
-0.12 (-7.2%)
At close:
1.65 USD
+0.04 (+2.48%)
After Hours:

This ZKIN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. ZKIN Profitability Analysis

1.1 Basic Checks

  • In the past year ZKIN has reported negative net income.
  • ZKIN had a positive operating cash flow in the past year.
  • In the past 5 years ZKIN always reported negative net income.
  • ZKIN had negative operating cash flow in 4 of the past 5 years.
ZKIN Yearly Net Income VS EBIT VS OCF VS FCFZKIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M

1.2 Ratios

  • ZKIN has a Return On Assets of -6.34%. This is in the lower half of the industry: ZKIN underperforms 61.64% of its industry peers.
  • ZKIN's Return On Equity of -16.27% is on the low side compared to the rest of the industry. ZKIN is outperformed by 66.04% of its industry peers.
Industry RankSector Rank
ROA -6.34%
ROE -16.27%
ROIC N/A
ROA(3y)-37.96%
ROA(5y)-24.29%
ROE(3y)-89.87%
ROE(5y)-56.22%
ROIC(3y)N/A
ROIC(5y)N/A
ZKIN Yearly ROA, ROE, ROICZKIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

1.3 Margins

  • ZKIN's Gross Margin of 5.67% is on the low side compared to the rest of the industry. ZKIN is outperformed by 62.26% of its industry peers.
  • ZKIN's Gross Margin has improved in the last couple of years.
  • ZKIN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 5.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.58%
GM growth 5Y4.77%
ZKIN Yearly Profit, Operating, Gross MarginsZKIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ZKIN Health Analysis

2.1 Basic Checks

  • ZKIN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ZKIN has been increased compared to 1 year ago.
  • ZKIN has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for ZKIN is higher compared to a year ago.
ZKIN Yearly Shares OutstandingZKIN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M
ZKIN Yearly Total Debt VS Total AssetsZKIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • ZKIN has an Altman-Z score of 0.59. This is a bad value and indicates that ZKIN is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.59, ZKIN is not doing good in the industry: 81.76% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of ZKIN is 324.85, which is on the high side as it means it would take ZKIN, 324.85 years of fcf income to pay off all of its debts.
  • ZKIN's Debt to FCF ratio of 324.85 is in line compared to the rest of the industry. ZKIN outperforms 55.35% of its industry peers.
  • ZKIN has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.47, ZKIN is not doing good in the industry: 68.55% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 324.85
Altman-Z 0.59
ROIC/WACCN/A
WACC8.36%
ZKIN Yearly LT Debt VS Equity VS FCFZKIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

2.3 Liquidity

  • ZKIN has a Current Ratio of 1.44. This is a normal value and indicates that ZKIN is financially healthy and should not expect problems in meeting its short term obligations.
  • ZKIN's Current ratio of 1.44 is on the low side compared to the rest of the industry. ZKIN is outperformed by 72.33% of its industry peers.
  • A Quick Ratio of 1.02 indicates that ZKIN should not have too much problems paying its short term obligations.
  • ZKIN has a Quick ratio of 1.02. This is in the lower half of the industry: ZKIN underperforms 66.04% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.02
ZKIN Yearly Current Assets VS Current LiabilitesZKIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. ZKIN Growth Analysis

3.1 Past

  • ZKIN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.19%.
  • ZKIN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -34.16%.
  • The Revenue has been decreasing by -3.87% on average over the past years.
EPS 1Y (TTM)-24.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.56%
Revenue 1Y (TTM)-34.16%
Revenue growth 3Y-11.39%
Revenue growth 5Y-3.87%
Sales Q2Q%-43.51%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZKIN Yearly Revenue VS EstimatesZKIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

More info and screens

Find the best growth stocksShow best growing peers

1

4. ZKIN Valuation Analysis

4.1 Price/Earnings Ratio

  • ZKIN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZKIN Price Earnings VS Forward Price EarningsZKIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZKIN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 329.44
EV/EBITDA N/A
ZKIN Per share dataZKIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. ZKIN Dividend Analysis

5.1 Amount

  • ZKIN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ZKIN Fundamentals: All Metrics, Ratios and Statistics

ZK INTERNATIONAL GROUP CO LT

NASDAQ:ZKIN (3/27/2026, 8:00:03 PM)

After market: 1.65 +0.04 (+2.48%)

1.61

-0.12 (-7.2%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-16
Earnings (Next)N/A
Inst Owners0.31%
Inst Owner Change0%
Ins Owners0.39%
Ins Owner ChangeN/A
Market Cap27.80M
Revenue(TTM)71.24M
Net Income(TTM)-3.99M
Analysts0
Price TargetN/A
Short Float %0.43%
Short Ratio3.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.39
P/FCF 329.44
P/OCF 37.76
P/B 1.13
P/tB 1.19
EV/EBITDA N/A
EPS(TTM)-0.67
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0
FCFY0.3%
OCF(TTM)0.04
OCFY2.65%
SpS4.13
BVpS1.42
TBVpS1.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.34%
ROE -16.27%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 5.67%
FCFM 0.12%
ROA(3y)-37.96%
ROA(5y)-24.29%
ROE(3y)-89.87%
ROE(5y)-56.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.58%
GM growth 5Y4.77%
F-Score3
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 324.85
Debt/EBITDA N/A
Cap/Depr 75.02%
Cap/Sales 0.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.02
Altman-Z 0.59
F-Score3
WACC8.36%
ROIC/WACCN/A
Cap/Depr(3y)127.07%
Cap/Depr(5y)145.32%
Cap/Sales(3y)1.18%
Cap/Sales(5y)1.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.19%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-20.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-34.16%
Revenue growth 3Y-11.39%
Revenue growth 5Y-3.87%
Sales Q2Q%-43.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-124%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y101.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.71%
OCF growth 3YN/A
OCF growth 5Y9.87%

ZK INTERNATIONAL GROUP CO LT / ZKIN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ZK INTERNATIONAL GROUP CO LT?

ChartMill assigns a fundamental rating of 1 / 10 to ZKIN.


What is the valuation status of ZK INTERNATIONAL GROUP CO LT (ZKIN) stock?

ChartMill assigns a valuation rating of 1 / 10 to ZK INTERNATIONAL GROUP CO LT (ZKIN). This can be considered as Overvalued.


Can you provide the profitability details for ZK INTERNATIONAL GROUP CO LT?

ZK INTERNATIONAL GROUP CO LT (ZKIN) has a profitability rating of 1 / 10.